128 related articles for article (PubMed ID: 20101129)
1. Is prophylactic fixation a cost-effective method to prevent a future contralateral fragility hip fracture?
Faucett SC; Genuario JW; Tosteson AN; Koval KJ
J Orthop Trauma; 2010 Feb; 24(2):65-74. PubMed ID: 20101129
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Fixation Can Be Cost-effective in Preventing a Contralateral Bisphosphonate-associated Femur Fracture.
Jiang SY; Kaufman DJ; Chien BY; Longoria M; Shachter R; Bishop JA
Clin Orthop Relat Res; 2019 Mar; 477(3):480-490. PubMed ID: 30394950
[TBL] [Abstract][Full Text] [Related]
3. Is prophylactic fixation a cost-effective method to prevent a future contralateral fragility hip fracture?
Wiwanitkit V
J Orthop Trauma; 2010 Jun; 24(6):e65; author reply e65. PubMed ID: 20502208
[No Abstract] [Full Text] [Related]
4. Can hip protector use cost-effectively prevent fractures in community-dwelling geriatric populations?
Honkanen LA; Mushlin AI; Lachs M; Schackman BR
J Am Geriatr Soc; 2006 Nov; 54(11):1658-65. PubMed ID: 17087691
[TBL] [Abstract][Full Text] [Related]
5. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
Moriwaki K; Noto S
Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture.
Zarca K; Durand-Zaleski I; Roux C; Souberbielle JC; Schott AM; Thomas T; Fardellone P; Benhamou CL
Osteoporos Int; 2014 Jun; 25(6):1797-806. PubMed ID: 24691648
[TBL] [Abstract][Full Text] [Related]
8. The Economic Impact of Acetabular Labral Tears: A Cost-effectiveness Analysis Comparing Hip Arthroscopic Surgery and Structured Rehabilitation Alone in Patients Without Osteoarthritis.
Lodhia P; Gui C; Chandrasekaran S; Suarez-Ahedo C; Dirschl DR; Domb BG
Am J Sports Med; 2016 Jul; 44(7):1771-80. PubMed ID: 27190068
[TBL] [Abstract][Full Text] [Related]
9. Effect and offset of effect of treatments for hip fracture on health outcomes.
Jonsson B; Kanis J; Dawson A; Oden A; Johnell O
Osteoporos Int; 1999; 10(3):193-9. PubMed ID: 10525710
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of fixation options for intertrochanteric hip fractures.
Swart E; Makhni EC; Macaulay W; Rosenwasser MP; Bozic KJ
J Bone Joint Surg Am; 2014 Oct; 96(19):1612-20. PubMed ID: 25274786
[TBL] [Abstract][Full Text] [Related]
11. A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.
Beaupre LA; Lier D; Smith C; Evens L; Hanson HM; Juby AG; Kivi P; Majumdar SR;
Arch Osteoporos; 2020 Jul; 15(1):113. PubMed ID: 32699946
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
[TBL] [Abstract][Full Text] [Related]
13. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
[TBL] [Abstract][Full Text] [Related]
14. Cost-Utility Analysis of the Ontario Fracture Screening and Prevention Program.
Saunders H; Sujic R; Bogoch ER; Jain R; Jinah A; Elliot-Gibson V; Mendlowitz AB; Linton D; Inrig T; Isaranuwatchai W; Sale JEM
J Bone Joint Surg Am; 2021 Jul; 103(13):1175-1183. PubMed ID: 33764937
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
16. Reverse Total Shoulder Arthroplasty Is the Most Cost-effective Treatment Strategy for Proximal Humerus Fractures in Older Adults: A Cost-utility Analysis.
Abdel Khalik H; Humphries B; Zoratti M; Axelrod D; Kruse C; Ristevski B; Rajaratnam K; Gardner M; Tarride JÉ; Johal H
Clin Orthop Relat Res; 2022 Oct; 480(10):2013-2026. PubMed ID: 35507306
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a multidisciplinary co-management program for the older hip fracture patients in Beijing.
Peng K; Yang M; Tian M; Chen M; Zhang J; Wu X; Ivers R; Si L
Osteoporos Int; 2020 Aug; 31(8):1545-1553. PubMed ID: 32219498
[TBL] [Abstract][Full Text] [Related]
18. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of treatment of women aged 70 years and older with both osteopenia and microstructural deterioration.
Liew D; Chapurlat RD; Sornay-Rendu E; Lespessailles E; Peng Y; Seeman E
Bone; 2021 Jan; 142():115682. PubMed ID: 33039577
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
